A commentary on interpreting the United States preventive services task force autism screening recommendation...

Area of Science:

• Pediatric Health
• Public Health Policy
• Developmental Pediatrics

Background:

• The US Preventive Services Task Force (USPSTF) issued an "I" statement in 2016 regarding universal primary care screening for autism spectrum disorder (ASD).
• This conclusion generated significant debate within research and clinical fields.
• Existing literature primarily focuses on the benefits of ASD screening, neglecting potential harms.

Purpose of the Study:

• To clarify the USPSTF's methodology for conceptualizing and evaluating potential harms of screening interventions.
• To analyze how potential harms were addressed in the USPSTF's "I" statement on ASD screening.
• To provide guidance for researchers investigating the benefits and harms of ASD screening.

Main Methods:

• Commentary and analysis of USPSTF harm evaluation frameworks.
• Review of the USPSTF's 2016 "I" statement on autism spectrum disorder screening.
• Discussion of conceptual and operational definitions of harm in preventive services.

Main Results:

• The USPSTF's approach to operationalizing harm in preventive screening requires further clarification.
• The "I" statement on ASD screening did not adequately detail the assessment of potential harms.
• A significant evidence gap exists regarding the harms associated with autism spectrum disorder screening.

Conclusions:

• Understanding the USPSTF's harm evaluation is crucial for designing effective research on ASD screening.
• Future research must prioritize the investigation of potential harms to balance the evidence on screening benefits.
• Ensuring that the benefits of autism spectrum disorder screening outweigh the harms is essential for all children and families.